132-136 Sly

نویسندگان

  • David F. Sly
  • David Quadagno
  • Dianne F. Harrison
  • Kara Riehman
چکیده

likely than nonusers to engage in risky sexual behavior and that they are less likely than nonusers to rely on condoms. In some studies, condom use has been treated as one component of a sexual-risk index, which is then related to substance use. In other research, condom use has been treated as a separate independent variable, which is then related to substance use directly. In this article, we separate condom use from other forms of sexual risk-taking (such as having multiple partners or exchanging sex for money or drugs). This allows us to consider the separate associations between substance use and sexual risk-taking and between substance use and condom use, as well as the joint effect of substance use and sexual risk-taking on condom use. More important, by separating other sexual risks from condom use in our analysis, we can evaluate condom use in four different contexts: situations combining substance use and risky sex; situations involving substance use but no risky sex; situations involving no substance use but risky sex; and situations combining no substance use and no risky sex. Most researchers have hypothesized that substance use is associated with higher sexual risk-taking and reduced condom use because it lowers inhibitions and impairs judgment.5 If this is the case, we would expect to find the lowest rates of condom use among persons who use substances, irrespective of their sexual riskDavid F. Sly is professor with the Center for the Study of Population; David Quadagno is professor in the Department of Biological Sciences; Dianne F. Harrison is dean of the School of Social Work; and Isaac W. Eberstein is a professor and Kara Riehman is a graduate assistant with the Center for the Study of Population; all at Florida State University, Tallahassee, Fla. The research on which this article is based was supported by grant Ro1HD31025-01-04 from the National Institutes of Health. The Association Between Substance Use, Condom Use And Sexual Risk Among Low-Income Women

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pharmacoeconomics 2008; 26 (2): 131-148

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132 1. Basic Concepts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132 1.1 Defining Terms . . . . . . . . . . . . . . . . . . . ...

متن کامل

Biochemical aspects................................................................................ 102

Explanation.................................................................................................... 101 Evaluation for acceptable daily intake .......................................................... 102 Biochemical aspects ................................................................................ 102 Absorption, distribution and excretion ......................................

متن کامل

Feasibility of Cap-Assisted Endoscopic Retrograde Cholangiopancreatography in Patients with Altered Gastrointestinal Anatomy

BACKGROUND/AIMS Endoscopic retrograde cholangiopancreatography (ERCP) is technically challenging in patients with altered gastrointestinal (GI) anatomy. We evaluated the feasibility of cap-assisted ERCP in patients with altered GI anatomy. METHODS The outcome of ERCP procedures (n=136) was analyzed in 78 patients with Billroth II (B-II) gastrectomy (n=72), Roux-en-Y total gastrectomy (n=4), a...

متن کامل

Table DP-1. Profile of General Demographic Characteristics: 2000 Geographic area: Ellsworth city, Kansas

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132 4.5 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136 4.6 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153 5.2 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175 5.9 20 to 24 years . . . . . . . . . . . . . . . . . . . . ....

متن کامل

Evidence-Based Practice

What is Evidence-Based Treatment? 130 What is Research Evidence? 130 Quality of the Evidence 131 Relevance of the Evidence 132 Where does One Find Evidence? 132 What is the Evidence Telling Us? 134 What is Clinical Expertise? 134 Components of Clinical Expertise 136 Enhancing Clinical Expertise 137 When is Clinical Expertise Present? 138 New Competencies Required for EBP 138 Identification of C...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2003